The IPO Buzz: Belgian Biotech AgomAb Therapeutics Joins Healthcare Heat Wave
AgomAb Therapeutics (AGMB Proposed) of Belgium is the latest biotech deal to join next week’s growing IPO Calendar – a heat wave of healthcare IPOs for the first week of February. The company disclosed the terms for its $200 million IPO early today in an SEC filing: 12.5 million American Depositary Shares (ADS) at a […]
January 29, 2026 Read More